457 related articles for article (PubMed ID: 18922644)
1. Evaluation of international treatment guidelines and prognostic tests for the treatment of early breast cancer.
Muñoz M; Estévez LG; Alvarez I; Fernández Y; Margelí M; Tusquets I; Seguí MA; Lluch A
Cancer Treat Rev; 2008 Dec; 34(8):701-9. PubMed ID: 18922644
[TBL] [Abstract][Full Text] [Related]
2. [Breast cancer treatment].
Duodecim; 2005; 121(3):317-8. PubMed ID: 15787290
[No Abstract] [Full Text] [Related]
3. Personalized treatment of early-stage breast cancer: present concepts and future directions.
Harbeck N; Salem M; Nitz U; Gluz O; Liedtke C
Cancer Treat Rev; 2010 Dec; 36(8):584-94. PubMed ID: 20554119
[TBL] [Abstract][Full Text] [Related]
4. Bio-pathologic characteristics related to chromosome 11 aneusomy and cyclin D1 gene status in surgically resected stage I and II breast cancer: Identification of an adverse prognostic profile.
Mottolese M; Orlandi G; Sperduti I; Merola R; Buglioni S; Di Benedetto A; Pinnarò P; Perracchio L; Venturo I; Cognetti F; Cianciulli A
Am J Surg Pathol; 2007 Feb; 31(2):247-54. PubMed ID: 17255770
[TBL] [Abstract][Full Text] [Related]
5. The management of early breast carcinoma before and after the introduction of clinical practice guidelines.
White V; Pruden M; Giles G; Collins J; Jamrozik K; Inglis G; Boyages J; Hill D
Cancer; 2004 Aug; 101(3):476-85. PubMed ID: 15274060
[TBL] [Abstract][Full Text] [Related]
6. Is adjuvant chemotherapy useful for women with luminal a breast cancer?
Coates AS; Colleoni M; Goldhirsch A
J Clin Oncol; 2012 Apr; 30(12):1260-3. PubMed ID: 22355052
[No Abstract] [Full Text] [Related]
7. Small tumor size and node-negative HER2-positive breast cancer: a step forward for a better treatment?
Crivellari D; Molino A
J Clin Oncol; 2010 Jun; 28(16):e257; author reply e258-9. PubMed ID: 20368536
[No Abstract] [Full Text] [Related]
8. Role of endocrine responsiveness and HER2/neu overexpression in inflammatory breast cancer treated with multimodality preoperative therapy.
D'Alessandro C; Dellapasqua S; Orlando L; Santoro L; Maisonneuve P; Torrisi R; Balduzzi A; Scarano E; Ghisini R; Peruzzotti G; Goldhirsch A; Colleoni M
Breast J; 2008; 14(5):435-41. PubMed ID: 18821931
[TBL] [Abstract][Full Text] [Related]
9. The effect of dedicated breast surgeons on the short-term outcomes in breast cancer.
Zork NM; Komenaka IK; Pennington RE; Bowling MW; Norton LE; Clare SE; Goulet RJ
Ann Surg; 2008 Aug; 248(2):280-5. PubMed ID: 18650639
[TBL] [Abstract][Full Text] [Related]
10. Improving decision-making in early breast cancer: who to treat and how?
Llombart-Cussac A
Breast Cancer Res Treat; 2008 Dec; 112 Suppl 1():15-24. PubMed ID: 19082929
[TBL] [Abstract][Full Text] [Related]
11. High-dose chemotherapy and stem cell transplantation does not improve relapse-free or overall survival in women with high-risk breast cancer.
Carlson RW; Wheatley K
Cancer Treat Rev; 2004 Feb; 30(1):131-7. PubMed ID: 14766131
[No Abstract] [Full Text] [Related]
12. Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel.
Millar EK; Graham PH; O'Toole SA; McNeil CM; Browne L; Morey AL; Eggleton S; Beretov J; Theocharous C; Capp A; Nasser E; Kearsley JH; Delaney G; Papadatos G; Fox C; Sutherland RL
J Clin Oncol; 2009 Oct; 27(28):4701-8. PubMed ID: 19720911
[TBL] [Abstract][Full Text] [Related]
13. Ki-67 expression gives additional prognostic information on St. Gallen 2007 and Adjuvant! Online risk categories in early breast cancer.
Jung SY; Han W; Lee JW; Ko E; Kim E; Yu JH; Moon HG; Park IA; Oh DY; Im SA; Kim TY; Hwang KT; Kim SW; Noh DY
Ann Surg Oncol; 2009 May; 16(5):1112-21. PubMed ID: 19219507
[TBL] [Abstract][Full Text] [Related]
14. Influence of genomics on adjuvant treatments for pre-invasive and invasive breast cancer.
Abu-Khalf M; Pusztai L
Breast; 2013 Aug; 22 Suppl 2():S83-7. PubMed ID: 24074799
[TBL] [Abstract][Full Text] [Related]
15. [Guideline 'Treatment of breast cancer 2008' (revision)].
Struikmans H; Nortier JW; Rutgers EJ; Zonderland HM; Bontenbal M; Elkhuizen PH; van Tienhoven G; Tjan-Heijnen VC; van Vegchel T; Tuut MK; Benraadt J
Ned Tijdschr Geneeskd; 2008 Nov; 152(46):2507-11. PubMed ID: 19055257
[TBL] [Abstract][Full Text] [Related]
16. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O;
Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568
[TBL] [Abstract][Full Text] [Related]
17. Approach and management of primary ectopic breast carcinoma in the axilla: where are we? A comprehensive historical literature review.
Visconti G; Eltahir Y; Van Ginkel RJ; Bart J; Werker PM
J Plast Reconstr Aesthet Surg; 2011 Jan; 64(1):e1-11. PubMed ID: 20934398
[TBL] [Abstract][Full Text] [Related]
18. Perineural invasion after preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation.
Jhawer M; Coit D; Brennan M; Qin LX; Gonen M; Klimstra D; Tang L; Kelsen DP; Shah MA
Am J Clin Oncol; 2009 Aug; 32(4):356-62. PubMed ID: 19381079
[TBL] [Abstract][Full Text] [Related]
19. Management of locally advanced breast cancer. Mini-review.
Franceschini G; Terribile D; Fabbri C; Magno S; D'Alba P; Chiesa F; Di Leone A; Masetti R
Minerva Chir; 2007 Aug; 62(4):249-55. PubMed ID: 17641585
[TBL] [Abstract][Full Text] [Related]
20. Multiple biomarkers in molecular oncology. II. Molecular diagnostics applications in breast cancer management.
Malinowski DP
Expert Rev Mol Diagn; 2007 May; 7(3):269-80. PubMed ID: 17489734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
